Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anandamide transport.

Matthew J McFarland1, Eric L Barker

  • 1Department of Medical Chemistry and Molecular Pharmacology, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907-2091, USA.

Pharmacology & Therapeutics
|November 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endocannabinoids and Fear-Related Behavior in Mice Selectively Bred for High or Low Alcohol Preference.

Brain sciences·2019
Same author

Corrigendum to "The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux" [Biochem. Pharmacol. 120 (2016) 46-55].

Biochemical pharmacology·2017
Same author

Myocutaneous Gracilis Free Flaps in Microsurgical Breast Reconstruction: A Systematic Review Comparing Variations of the Upper Gracilis Flap.

Journal of reconstructive microsurgery·2017
Same author

The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux.

Biochemical pharmacology·2016
Same author

Assessing cholesterol storage in live cells and C. elegans by stimulated Raman scattering imaging of phenyl-Diyne cholesterol.

Scientific reports·2015
Same author

4-Aminocyclopentane-1,3-diols as platforms for diversity: synthesis of anandamide analogs.

Medicinal chemistry (Shariqah (United Arab Emirates))·2012
Same journal

Protein acetylation modification in tissue fibrosis: Opportunities and challenges.

Pharmacology & therapeutics·2026
Same journal

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Pharmacology & therapeutics·2026
Same journal

C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

Pharmacology & therapeutics·2026
Same journal

The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation.

Pharmacology & therapeutics·2026
Same journal

Glymphatic-meningeal lymphatic dysfunction in epilepsy: novel mechanistic insights and therapeutic avenues.

Pharmacology & therapeutics·2026
Same journal

The neurovascular unit under siege: Molecular mechanisms and potential drug target for cerebral edema.

Pharmacology & therapeutics·2026
See all related articles

N-Arachidonylethanolamine (anandamide) transport into cells is crucial for regulating signaling. Inhibiting this transport offers potential therapeutic strategies for endocannabinoid system-related diseases.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • N-Arachidonylethanolamine (anandamide) is an endogenous cannabinoid receptor agonist.
  • Anandamide shares physiological effects with delta9-tetrahydrocannabinol (delta9-THC).
  • Tight regulation of anandamide signaling and metabolism is essential.

Purpose of the Study:

  • To review current models of anandamide transport mechanisms.
  • To discuss inhibitors of anandamide transport.
  • To explore therapeutic applications of anandamide transport inhibition.

Main Methods:

  • Literature review of anandamide transport mechanisms.
  • Analysis of compounds inhibiting anandamide transport.
  • Evaluation of in vivo effects and therapeutic potential.

Related Experiment Videos

Main Results:

  • Anandamide transport is a key regulatory process.
  • Development of specific anandamide transport inhibitors is progressing.
  • Inhibition shows potential therapeutic benefits.

Conclusions:

  • Anandamide transport is a critical target for therapeutic intervention.
  • Inhibitors of anandamide transport represent a promising drug development avenue.
  • Further research into therapeutic applications is warranted.